Clinical Trials Browser

Phase 2/3 × lanreotide × Clear all

NCT02288377 2023-01-18

REMINET

Phase 2/3 Terminated

53 enrolled 11 charts

Neoplasm Metastasis

NCT00495846 2009-08-17

SS-HCC

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular